Specific role of lymphatic marker podoplanin in retinal pigment epithelial cells

Lymphology

Volumn 43, Issue 3, 2010, Pages 128-134

  Grimaldo, S ^a   Garcia, M ^a   Zhang, H ^a   Chen, Lu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Lymphatic; Podoplanin; Retinal pigment epithelium; siRNA

Indexed keywords

LYMPHOCYTE SURFACE MARKER; PODOPLANIN; SMALL INTERFERING RNA; VISUAL PIGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL AGGREGATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; EYE DISEASE; GENE SILENCING; HUMAN; HUMAN CELL; MALE; NONHUMAN; PIGMENT CELL; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROTEIN DEPLETION; PROTEIN LOCALIZATION; RAT; RETINA MACULA AGE RELATED DEGENERATION; VISION;

ANIMALS; BIOLOGICAL MARKERS; CELL COMMUNICATION; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; PIGMENT EPITHELIUM OF EYE;

EID: 78650354087     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Breiteneder-Geleff, S, A Soleiman, H Kowalski, et al: Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 154 (1999), 385-394.
2. Schacht, V, M Ramirez, Y Hong, et al: T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22 (2003), 3546-3556.
3. Breiteneder-Geleff, S, K Matsui, A Soleiman, et al: Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am. J. Pathol. 151 (1997), 1141-1152.
4. Gonzalez, R, L Dobbs: Purification and analysis of RTI40, a type I alveolar epithelial cell apical membrane protein. Biochim. Biophys. Acta. 1429 (1998), 208-216.
5. Williams, M, Y Cao, A Hinds, et al: T1 alpha protein is developmentally regulated and expressed by alveolar type I cells, choroid plexus, and ciliary epithelia of adult rats. Am. J. Respir. Cell. Mol. Biol. 14 (1996), 577-585.
6. Simo, R, M Villarroel, L Corraliza, et al: The retinal pigment epithelium: Something more than a constituent of the blood-retinal barrier - implications for the pathogenesis of diabetic retinopathy. J. Biomed. Biotechnol. 2010;2010:190724. Epub 2010 Feb 17.
7. Erickson, K, J Sundstrom, D Antonetti: Vascular permeability in ocular disease and the role of tight junctions. Angiogenesis 10 (2007), 103-117.
8. Strauss, O: The retinal pigment epithelium in visual function. Physiol. Rev. 85 (2005), 845-881.
9. Ecoiffier, T, D Yuen, L Chen: Differential distribution of blood and lymphatic vessels in the murine cornea. Invest. Ophthalmol. Vis. Sci. 51 (2010), 2436-2440.
10. Zhang, H, J Tse, X Hu, et al: Novel discovery of LYVE-1 expression in the hyaloid vascular system. Invest. Ophthalmol. Vis. Sci. (2010), Aug 4. [Epub ahead of print].
11. Zhang, H, X Hu, J Tse, et al: Spontaneous lymphatic vessel formation and regression in the murine cornea. Invest Ophthalmol. Vis. Sci. (2010). Aug 25. [Epub ahead of print]
12. Schacht, V, S Dadras, L Johnson, et al: Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am. J. Pathol. 166 (2005), 913-921.
13. Hilkens, J, M Ligtenberg, H Vos, et al: Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem. Sci. 17 (1992), 359-363.
14. Matter, K, M Balda: Occludin and the functions of tight junctions. Int. Rev. Cytol. 186 (1999), 117-146.
15. Abe, T, E Sugano, Y Saigo, et al: Interleukin- 1beta and barrier function of retinal pigment epithelial cells (ARPE-19): Aberrant expression of junctional complex molecules. Invest. Ophthalmol. Vis. Sci. 44 (2003), 4097-4104.
16. Jin, M, E Barron, S He, et al: Regulation of RPE intercellular junction integrity and function by hepatocyte growth factor. Invest. Ophthalmol. Vis. Sci. 43 (2002), 2782-2790.
17. Miyamoto, N, Y de Kozak, J Jeanny, et al: Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: Potential implication in the pathogenesis of diabetic retinopathy. Diabetologia 50 (2007), 461-470.
18. Campochiaro, P: Pathogenic mechanisms in proliferative vitreoretinopathy. Arch. Ophthalmol. 115 (1997), 237-241.
19. Esser, P, K Heimann, K Bartz-Schmidt, et al: Apoptosis in proliferative vitreoretinal disorders: Possible involvement of TGF-beta-induced RPE cell apoptosis. Exp. Eye Res. 65 (1997), 365-378.
20. Miller, H, B Miller, S Ryan: The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest. Ophthalmol. Vis. Sci. 27 (1986), 1644-1652.
21. Blumenkranz, M, A Ophir, A Claflin, et al: Fluorouracil for the treatment of massive periretinal proliferation. Am. J. Ophthalmol. 94 (1982), 458-467.
22. Stern, W, G Lewis, P Erickson, et al: Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy. Am. J. Ophthalmol. 96 (1983), 33-42.
23. Charteris, D, C Sethi, G Lewis, et al: Proliferative vitreoretinopathy- developments in adjunctive treatment and retinal pathology. Eye (Lond) 16 (2002), 369-374.
24. Chen, L: Ocular lymphatics: State-of-the-art review. Lymphology 42 (2009), 66-76.